Appnotes
Cergentis and its partners have published various application notes about the TLA technology, its applications and the automation of the TLA protocol.
Please select an application to review the corresponding appnotes:
- Cell and Gene Therapy
Application note on targeted complete NGS and QC of transgenes and integration sites in upstream cell and gene therapy manufacturing
Application note on targeted complete NGS and QC of transgenes, integration sites and gene editing in heterogeneous cell and gene therapy products- Cell Line Development
Application note: Automated TLA for Targeted Complete Transgene & Integration Sequencing in Pharmaceutical Cell Line Development & Quality Control
Application note on the use of the TLA technology in transgene and integration site sequencing in CHO cell lines.
Application note on Genedata Selector for Efficient and High Quality CHO Cell Line Development - Leveraging TLA for complete sequencing of expression constructs and integration sites- Genome Editing
Appnote: TLA for complete locus sequencing and quality control of targeted genome editing- Clinical Genetics
Poster: TLA & Long Read Sequencing: Efficient Targeted Sequencing and Phasing of the CFTR Gene
Application Note Pacific Biosciences - Targeted Sequencing and Chromosomal Haplotype Assembly Using Cergentis TLA Technology with PacBio SMRT Sequencing.
Application note on the TLA protocol for isolated genomic DNA.- Automation
- Application note: Automated TLA for Targeted Complete Transgene & Integration Sequencing in Pharmaceutical Cell Line Development & Quality Control
- Transgenic Models
Application note on TLA-based transgene and -integration site sequencing.- Leukaemia
Application note on the application of TLA in gene fusion detection in pediatric leukaemia
Application note on MRD testing using TLA data- Solid Tumours
